NI
63
3
ROK
42
4
MPC
31
5
EQT
30
5
STI
28
9
MKC
56
3
AZO
50
2
BAC
39
3
PFG
36
3
MAS
59
3
AA
47
4
AES
44
3
MLM
58
-2
AMAT
46
6
PHM
60
6
GIS
29
3
RRC
50
4
NWS
62
4
RIG
58
3
AVB
54
9
NI
63
3
ROK
42
4
MPC
31
5
EQT
30
5
STI
28
9
MKC
56
3
AZO
50
2
BAC
39
3
PFG
36
3
MAS
59
3
AA
47
4
AES
44
3
MLM
58
-2
AMAT
46
6
PHM
60
6
GIS
29
3
RRC
50
4
NWS
62
4
RIG
58
3
AVB
54
9
Financhill
Back

Akari Therapeutics PLC Vs. Cellectis SA Industry Stock Comparison

Sell
40

AKTX
Akari Therapeutics PLC

Last Price:
2.23
Seasonality Move:
-3.74%
Sell
46

CLLS
Cellectis SA

Last Price:
1.78
Seasonality Move:
26.52%
Sell
40
Akari Therapeutics PLC (AKTX) is a Sell

Is Akari Therapeutics PLC a Buy, Sell or Hold?

  • The current Akari Therapeutics PLC [AKTX] share price is $2.43. The Score for AKTX is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • AKTX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
46
Cellectis SA (CLLS) is a Sell

Is Cellectis SA a Buy, Sell or Hold?

  • The current Cellectis SA [CLLS] share price is $1.78. The Score for CLLS is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • CLLS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

AKTX Stock Price Chart

What is Akari Therapeutics PLC's stock price today?

  • The Akari Therapeutics PLC share price today is $2.43
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKTX is experiencing buying pressure, which is a positive indicator for future bullish movement.

CLLS Stock Price Chart

What is Cellectis SA's stock price today?

  • The Cellectis SA share price today is $1.78
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CLLS is experiencing selling pressure, which indicates risk of future bearish movement.

AKTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.14 Sell
Relative Strength Index (14 RSI): 43.98 Sell
Chaikin Money Flow: 19777 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.29 - 2.89) Sell
Bollinger Bands (100): (2.71 - 3.71) Sell

CLLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.08 Sell
Relative Strength Index (14 RSI): 38.6 Sell
Chaikin Money Flow: -184551 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.82 - 1.98) Sell
Bollinger Bands (100): (1.92 - 2.26) Sell

AKTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.46 Sell
20-day SMA: 2.49 Sell
50-day SMA: 2.98 Sell
200-day SMA: 2.57 Sell
8-day EMA: 2.46 Sell
20-day EMA: 2.55 Sell
50-day EMA: 2.82 Sell
200-day EMA: 3.04 Sell

CLLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.82 Sell
20-day SMA: 1.88 Sell
50-day SMA: 2.09 Sell
200-day SMA: 2.41 Sell
8-day EMA: 1.81 Sell
20-day EMA: 1.89 Sell
50-day EMA: 2.01 Sell
200-day EMA: 2.28 Sell

Akari Therapeutics PLC Earnings Growth & AKTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.60 per share, and a decrease next year of $0.00 per share.

Cellectis SA Earnings Growth & CLLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.76 per share, and a decrease next year of $0.35 per share.

Akari Therapeutics PLC Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Cellectis SA Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):